CanStem Therapeutics

Cancer is a deadly disease and represents a key drug development market. We strive to develop innovative therapies with lifesaving benefits to cancer patients.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Lausanne, Switzerland
  • Currency CHF
  • Founded 2014
  • Employees 1

Company Summary

CanStem Therapeutics is a developmental stage biotechnology company. Leveraging on more than 15 years of cancer research at EPFL, we are developing first-in-class and best-in-class targeted therapies against cancer by targeting key signaling cascades responsible for causing cancer. Development of novel targeted therapies represents an attractive alternative to conventional chemotherapies.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free